Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Approved for marketing × Neoplasms × Nivolumab × Clear all

Status

Completed 35 Active not recruiting 16 Recruiting 13 Terminated 7 Unknown 6 Withdrawn 3 Not yet recruiting 1 Approved for marketing 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

vorasidenib 1 tovorafenib 1 olaparib 1 glucarpidase 1 enzalutamide 1 adagrasib 1 Nivolumab 1 Carboxypeptidases 1 3-Iodobenzylguanidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03126643 2021-11-29

Expanded Access to Nivolumab (Opdivo)

Bristol-Myers Squibb

Approved for marketing

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡